Bristol Myers Squibb

💰 $4.5B Post-IPO Debt on 2023-10-30🫂 on 2023-08-11PharmaceuticalBiotechnologyMedicalPrecision MedicineHealth Care
Website LinkedIn Phone # Facebook Twitter

Bristol-Myers Squibb Company is a pharmaceutical company focused on discovering, developing, and selling medicines for oncology, cardiovascular, immunoscience, and fibrosis, with a commitment to improving patient outcomes and quality of life.